What does CUSIP 00791X118 represent in this 13F holders report?

CUSIP 00791X118 is the security identifier for AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 used to aggregate holder disclosures.

How many institutions held AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in Q2 2024?

No institutional holders were reported for AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in Q2 2024; review adjacent reporting periods for trend context.

202 (AEONWS)

CUSIP: 00791X118

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / *W EXP 07/21/202
Total 13F shares: 0
Share change: -2,279,341
Total reported value: $0
Number of holders: 0
Value change: -$3,328,191
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 00791X118?
CUSIP 00791X118 identifies AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2024

Recent filing periods for CUSIP 00791X118:

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS)

Q2 2024 13F Holders as of 30 Jun 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 as of Q2 2024.